Despite exhibiting a relatively lower CRISPR viability score in H28 cells, BUB1 depletion imposed a pronounced and selective growth disadvantage in cancer cells compared to nonmalignant controls (Fig. 3A). This evidence concerns the gene BUB1 and cancer.